terazosin

Generic: terazosin hydrochloride

Labeler: jubilant cadista pharmacuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler jubilant cadista pharmacuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 5 mg/1

Manufacturer
Jubilant Cadista Pharmacuticals Inc.

Identifiers & Regulatory

Product NDC 59746-385
Product ID 59746-385_58fe004c-b69e-422e-8089-2ab1b59ceb4c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2004-12-20

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59746385
Hyphenated Format 59746-385

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UPC
0359746385064 0359746386061 0359746383060 0359746384067
UNII
D32S14F082

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (59746-385-06)
  • 500 CAPSULE in 1 BOTTLE (59746-385-09)
  • 1000 CAPSULE in 1 BOTTLE (59746-385-10)
  • 90 CAPSULE in 1 BOTTLE (59746-385-90)
source: ndc

Packages (4)

Ingredients (1)

terazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "58fe004c-b69e-422e-8089-2ab1b59ceb4c", "openfda": {"upc": ["0359746385064", "0359746386061", "0359746383060", "0359746384067"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["43e92495-2cf2-46dd-a80c-f0c3c88c7b73"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (59746-385-06)", "package_ndc": "59746-385-06", "marketing_start_date": "20041220"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (59746-385-09)", "package_ndc": "59746-385-09", "marketing_start_date": "20041220"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (59746-385-10)", "package_ndc": "59746-385-10", "marketing_start_date": "20041220"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (59746-385-90)", "package_ndc": "59746-385-90", "marketing_start_date": "20041220"}], "brand_name": "Terazosin", "product_id": "59746-385_58fe004c-b69e-422e-8089-2ab1b59ceb4c", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "59746-385", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Jubilant Cadista Pharmacuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20041220", "listing_expiration_date": "20261231"}